V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 270016648 | 270009549 | 1.59 | 67 | Neo-adjuvant (N) | 2014-03-12 | 2014-03-20 | CAPECITABINE + RT | N | N | 270016272 | CAPECITABINE + RT |
| 270016650 | 270016967 | 1.69 | 125 | Adjuvant (A) | null | 2017-03-02 | CAPECITABINE + RT | null | null | 270016283 | CAPECITABINE + RT |
| 270016651 | 270014467 | 1.61 | null | Palliative (P) | 2014-06-05 | 2014-06-08 | Capecitabine (21 day) + Irinotecan | N | N | 270016291 | CAPECITABINE + IRINOTECAN |
| 270016652 | 270009555 | 1.77 | 48.4 | null | 2015-03-31 | 2015-04-19 | Fluorouricil + Folonic Acid (MdG) | 2 | Y | 270016297 | FLUOROURACIL |
| 270016653 | 270009558 | 1.72 | 56 | Neo-adjuvant (N) | 2014-07-03 | 2014-07-17 | CAPECITABINE + RT | 02 | N | 270016298 | CAPECITABINE + RT |
| 270016654 | 270009560 | null | 61 | Adjuvant (A) | null | 2014-12-04 | Cetuximab + Radiotherapy Maint | N | N | 270016305 | CETUXIMAB + RT |
| 270016655 | 270016970 | null | 89.7 | Curative (C) | 2017-01-09 | 2018-09-09 | DHAP | N | N | 270016310 | DHAP |
| 270016656 | 270009564 | 1.6 | null | Curative (C) | 2018-07-13 | 2018-07-15 | CHOP R - 21 days | 02 | N | 270016323 | CHOP R |
| 270016657 | 270009565 | 1.65 | 58 | null | 2017-07-13 | 2018-06-21 | DHAP | 02 | N | 270016329 | DHAP |
| 270016658 | 270009566 | 1.84 | null | Adjuvant (A) | 2016-11-18 | 2018-08-21 | CISPLATIN + FLUOROURACIL | null | null | 270016336 | CISPLATIN + FLUOROURACIL |
| 270016659 | 270009568 | null | 68.95 | Palliative (P) | 2018-03-15 | 2018-03-18 | Cetuximab + Radiotherapy Maint | N | null | 270016339 | CETUXIMAB + RT |
| 270016660 | 270009568 | null | 88.2 | Neo-adjuvant (N) | 2014-12-27 | 2015-01-22 | Bevacizumab + Oxaliplatin +MdG | 2 | N | 270016339 | BEVACIZUMAB + OXALIPLATIN + MdG |
| 270016661 | 270009570 | 1.6 | 91 | Curative (C) | 2016-05-05 | 2016-12-15 | Shamash LBCMVD-56 | N | N | 270016354 | NOT MATCHED |
| 270016662 | 270009572 | 1.7 | 92.4 | Neo-adjuvant (N) | 2018-01-11 | 2018-01-16 | CAPECITABINE + RT | 2 | Y | 270016356 | CAPECITABINE + RT |
| 270016663 | 270009573 | 1.53 | 93 | Adjuvant (A) | null | 2015-02-05 | Capecitabine (14 day) + Irinotecan | 2 | N | 270016358 | CAPECITABINE + IRINOTECAN |
| 270016664 | 270014480 | 1.76 | 60 | Curative (C) | 2015-02-19 | 2015-02-27 | Cetuximab + Radiotherapy Maint | N | N | 270016359 | CETUXIMAB + RT |
| 270016665 | 270014480 | 1.73 | 56.4 | Palliative (P) | 2016-07-26 | 2016-09-07 | CAPECITABINE + RT | null | null | 270016359 | CAPECITABINE + RT |
| 270016666 | 270009577 | null | 94.7 | Not known (9) | null | 2018-06-21 | CHLVPP | N | N | 270016361 | CHLVPP |
| 270016667 | 270009578 | null | 67.9 | Disease modification (D) | 2014-07-06 | 2014-07-25 | CHLVPP | 2 | N | 270016362 | CHLVPP |
| 270016668 | 270009578 | 1.6 | 60 | Adjuvant (A) | 2018-04-25 | 2018-05-05 | Fluorouracil + Folinic Acid (Mayo) | 02 | Y | 270016362 | FLUOROURACIL |
| 270016669 | 270009583 | 1.9 | 86.5 | Palliative (P) | 2014-02-14 | 2014-03-08 | Trifluridine + Tipiracil | 02 | Y | 270016373 | TRIFLURIDINE + TIPIRACIL |
| 270016670 | 270014483 | 1.6 | 82 | Palliative (P) | 2013-01-02 | 2014-11-07 | CHLVPP | 2 | null | 270016378 | CHLVPP |
| 270016671 | 270014484 | 1.65 | 54 | Palliative (P) | 2016-08-19 | 2018-04-23 | CAPECITABINE + RT | 02 | Y | 270016380 | CAPECITABINE + RT |
| 270016672 | 270009587 | 1.78 | null | Curative (C) | 2013-06-01 | 2013-06-30 | null | N | N | 270016384 | NOT MATCHED |
| 270016673 | 270009590 | null | 68.1 | Curative (C) | null | 2014-08-12 | Cetuximab + Radiotherapy Maint | null | null | 270016387 | CETUXIMAB + RT |
| 270016674 | 270009591 | 1.6 | 60 | Not known (9) | 2018-12-14 | 2019-01-05 | CHLVPP | N | N | 270016396 | CHLVPP |
| 270016675 | 270009593 | 1.76 | 49.3 | Curative (C) | 2017-08-15 | 2017-09-12 | CHOP R | N | Y | 270016400 | CHOP R |
| 270016676 | 270009593 | 1.7 | 79.3 | Disease modification (D) | 2013-05-04 | 2014-02-26 | CHLVPP | N | N | 270016400 | CHLVPP |
| 270016677 | 270018415 | 1.6 | 142 | Curative (C) | 2014-11-08 | 2014-11-08 | CHLVPP | 2 | null | 270016405 | CHLVPP |
| 270016678 | 270009597 | 1.5 | 71 | Curative (C) | 2015-02-12 | 2015-03-13 | DHAP | 02 | N | 270016406 | DHAP |
| 270016679 | 270009602 | 1.72 | 72.4 | Curative (C) | 2017-04-27 | 2017-05-28 | Cetuximab + Radiotherapy Maint | N | N | 270016414 | CETUXIMAB + RT |
| 270016680 | 270009603 | null | 59.75 | Disease modification (D) | 2017-12-01 | 2018-01-05 | CHLVPP | 2 | N | 270016418 | CHLVPP |
| 270016681 | 270009605 | 0.91 | 64.75 | Palliative (P) | 2018-01-28 | 2018-01-28 | CHOP R - 21 days | N | N | 270016421 | CHOP R |
| 270016682 | 270009607 | 1.89 | 111.3 | Curative (C) | 2016-02-12 | 2016-02-14 | null | N | N | 270016426 | NOT MATCHED |
| 270016683 | 270009609 | 1.65 | 106 | Palliative (P) | null | 2018-02-21 | Capecitabine (14 day) + Irinotecan | N | N | 270016434 | CAPECITABINE + IRINOTECAN |
| 270016684 | 270009611 | 1.69 | 63 | Curative (C) | 2016-03-29 | 2016-03-29 | DHAP | 02 | N | 270016438 | DHAP |
| 270016685 | 270009612 | 1.59 | 82.2 | Not known (9) | 2018-02-28 | 2018-02-28 | Fluorouracil + Folinic Acid Weekly | N | null | 270016441 | FLUOROURACIL |
| 270016686 | 270009616 | 1.75 | 60 | Curative (C) | 2016-01-26 | 2016-02-25 | HD EuroNet-PHL-C1 Relapsed ABVD | 2 | N | 270016443 | NOT MATCHED |
| 270016687 | 270009617 | 1.82 | 59.2 | Disease modification (D) | 2016-10-01 | 2016-10-26 | Trifluridine + Tipiracil | N | N | 270016443 | TRIFLURIDINE + TIPIRACIL |
| 270016688 | 270019233 | null | null | Curative (C) | 2015-02-08 | 2015-02-20 | CHOP R - 14 days | N | N | 270016450 | CHOP R |
| 270016689 | 270009621 | 1.66 | 72 | Palliative (P) | 2017-08-18 | 2017-08-18 | Fluorouracil + Folinic Acid Weekly | N | N | 270016459 | FLUOROURACIL |
| 270016690 | 270018422 | 1.8 | 106 | Disease modification (D) | 2015-02-09 | 2015-03-22 | Shamash LBCMVD-56 | N | N | 270016464 | NOT MATCHED |
| 270016691 | 270009624 | 1.76 | 45.6 | Adjuvant (A) | 2016-12-02 | 2016-12-18 | HD EuroNet-PHL-C1 Relapsed ABVD | N | N | 270016480 | NOT MATCHED |
| 270016692 | 270014504 | null | null | Disease modification (D) | 2013-07-30 | 2013-09-01 | CHLVPP | 2 | null | 270016482 | CHLVPP |
| 270016693 | 270016994 | 1.7 | 79.8 | Disease modification (D) | 2014-12-18 | 2014-12-20 | CHLVPP | 02 | null | 270016490 | CHLVPP |
| 270016694 | 270014508 | 1.74 | 83.6 | Neo-adjuvant (N) | 2018-06-04 | 2018-06-04 | Cisplatin +Fluorouracil (3 wk) | N | N | 270016502 | CISPLATIN + FLUOROURACIL |
| 270016695 | 270014509 | 1.64 | 87 | Neo-adjuvant (N) | 2015-09-05 | 2015-09-05 | Bevacizumab + Oxaliplatin +MdG | 02 | N | 270016502 | BEVACIZUMAB + OXALIPLATIN + MdG |
| 270016696 | 270020161 | 1.59 | 90.9 | Adjuvant (A) | null | 2018-04-26 | CHLVPP | 2 | Y | 270016519 | CHLVPP |
| 270016697 | 270009637 | null | null | null | 2016-09-11 | 2016-12-13 | DHAP | null | null | 270016525 | DHAP |
| 270016698 | 270009640 | 1.6 | 66.9 | Curative (C) | 2018-04-08 | 2018-04-09 | CHLVPP | 02 | null | 270016528 | CHLVPP |